Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia

NATerminatedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

July 25, 2016

Study Completion Date

July 25, 2016

Conditions
Monomorphic Ventricular Tachycardia
Interventions
DEVICE

Cardiac catheter ablation with ICD/CRT-D

Cardiac ablation catheter system

Trial Locations (38)

5000

Royale Adelaide Hospital, Adelaide

10016

New York University Hospital, New York

New York University Langone Medical Center, New York

10029

Mt. Sinai Hospital, New York

10305

Staten Island University Hospital - North, Staten Island

13005

Hopital d'adulte de la Timone, Marseille

19118

Hospital of the University of Pennsylvania, Philadelphia

20010

Washington Hospital Center, Washington D.C.

20132

Ospedale San Raffaele, Milan

21201

University of Maryland Medical Center, Baltimore

21287

Johns Hopkins University Hospital, Baltimore

27710

Duke University Medical Center, Durham

28203

Sanger Clinic, Charlotte

30322

Emory University Hospital, Atlanta

33604

Hôpital du Haut Lévêque, Pessac

35294

University of Alabama at Birmingham, Birmingham

37170

CHU Trousseau, Chambray-lès-Tours

37232

Vanderbilt Heart and Vascular Institute, Nashville

44106

University Hospitals of Cleveland, Cleveland

55905

Mayo Clinic, Rochester

60153

Loyola University Medical Center, Maywood

63110

Barnes-Jewish Hospital, St Louis

Washington University School of Medicine - Barnes Jewish Hospital, St Louis

63141

Mercy Hospital St. Louis, St Louis

66160

Mid-America Cardiology Associates, Kansas City

69300

Clinique Protestante, Lyon

77030

The Methodist Hospital, Houston

77380

Memorial Hermann Hospital, The Woodlands

78705

Texas Cardiac Arrhythmia Research Foundation, Austin

84107

Intermountain Heart Rhythm Specialist, Murray

90033

USC University Hospital, Los Angeles

90095

Ronald Reagan UCLA Medical Center, Los Angeles

92103

University of California at San Diego (UCSD) Medical Center, San Diego

94143

University of California at San Francisco, San Francisco

98195

University of Washington Medical Center, Seattle

02114

Massachusetts General Hospital, Boston

NE7 7DN

Freeman Hospital, Newcastle upon Tyne

SE5 9RS

Kings College Hospital, London

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT02130765 - Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia | Biotech Hunter | Biotech Hunter